Elon Musk promised Neuralink would merge human minds with AI to grant superhuman abilities. Early trials show modest success in human subjects, but the company faces a grim history of primate testing failures. This gap between marketing and reality challenges the viability of high-bandwidth brain-computer interfaces. Practitioners should monitor clinical data over executive hype.